Industrial development of PhoS-Istos project

Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.

Analysis phase of PHOS-ISTOS clinical trial is now achieved

This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.

Interview of Pr. Mordon during the EADV congress

Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.

Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Back